EHT102

· Shanghai Euhearing Therapeutics Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EHT102, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations [Phase 1, Phase 2]